TENXConference•globenewswire•
Tenax Therapeutics to Participate in the Cantor Global Healthcare Conference 2025
Sentiment:Negative (30)
Summary
CHAPEL HILL, N.C., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax Therapeutics” or the “Company”), a Phase 3, development-stage pharmaceutical company using clinical insights to develop novel cardiopulmonary therapies, today announced that the Company will participate in a fireside chat at the Cantor Global Healthcare Conference 2025, which is taking place from September 3-5, 2025, in New York, NY.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 28, 2025 by globenewswire